Is iTonic Holdings Ltd. (NASDAQ:ITOC) a buy in 2026?
No. iTonic Holdings Ltd. is one to avoid for now, per the Compass.
A $8M Chinese brachytherapy software shell with a fresh name, burning cash at 7x revenue, and no institutional coverage for good reason.
Where ITOC is headed
Twelve months from now, iTonic will either have raised dilutive capital at a discount to a $0.33 share price, or it will be fighting a Nasdaq delisting notice. Those are the realistic outcomes for a company with an $8 million market cap, negative 682% operating margins, and a name change in January 2026 that swapped 'Pheton' for 'iTonic' without changing the underlying business, a Beijing-based brachytherapy planning software vendor controlled by a BVI parent.
Read the full Compass Direction on ITOC
The complete destination call, the overlooked angle, milestones, and bull, base, and bear price scenarios (around $4.02).
See the full ITOC analysisGet calls like this, free
Join the Alexandria e-letter for forward-looking verdicts, earnings intelligence, and the contrarian reads the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is iTonic Holdings Ltd. (NASDAQ:ITOC) a buy in 2026?
No. iTonic Holdings Ltd. is one to avoid for now, per the Compass. A $8M Chinese brachytherapy software shell with a fresh name, burning cash at 7x revenue, and no institutional coverage for good reason.
What is ITOC's Compass Score?
iTonic Holdings Ltd. scores 62/100 on Alexandria's Compass, placing it in the "Favorable" tier. Scores blend eight factors and update weekly.
What is the price target for ITOC?
Alexandria's full Compass Direction includes bull, base, and bear price scenarios with the valuation math behind each. Read the full breakdown on the ITOC page.
Compass verdicts are AI-generated, forward-looking editorial research from publicly available data, not investment advice or a recommendation regarding any security. Scores and verdicts update as the data changes.